Found: 2
Select item for more details and to access through your institution.
PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study.
- Published in:
- Asian Journal of Andrology, 2023, v. 25, n. 2, p. 179, doi. 10.4103/aja2022102
- By:
- Publication type:
- Article
Peripheral monocyte count: an independent diagnostic and prognostic biomarker for prostate cancer - a large Chinese cohort study.
- Published in:
- Asian Journal of Andrology, 2017, v. 19, n. 5, p. 579, doi. 10.4103/1008-682X.186185
- By:
- Publication type:
- Article